Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Alcohol Use Disorder in Veterans with TBI
NCT02791945Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) and traumatic brain injury (TBI) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Percent of Heavy Drinking Days Per Week at 8 weeks and Neurobehavioral Symptom Inventory at 8 weeks. Started Aug 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
alcohol use disorder (AUD)traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02791945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02791945.